for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Henan Taloph Pharmaceutical Stock Co.,

600222.SS

Latest Trade

4.33CNY

Change

-0.04(-0.92%)

Volume

1,793,370

Today's Range

4.31

 - 

4.38

52 Week Range

3.25

 - 

7.39

As of on the Shanghai Stock Exchange ∙ Minimum 15 minute delay

Latest Developments

Henan Taloph Pharmaceutical Elects Li Jingliang As Chairman

Sept 9 (Reuters) - Henan Taloph Pharmaceutical Stock Co Ltd <600222.SS>::SAYS BOARD ELECTS LI JINGLIANG AS CHAIRMAN.

Henan Taloph Pharmaceutical Revises Share Buyback Plan To 125-250 Million Yuan

Jan 31 (Reuters) - Henan Taloph Pharmaceutical Stock Co Ltd <600222.SS>::SAYS IT REVISES SHARE BUYBACK PLAN TO 125-250 MILLION YUAN ($18.63-$37.26 million) FROM 20-250 MILLION YUAN PREVIOUSLY.

Henan Taloph Pharmaceutical To Boost Unit's Capital Via Debt-To-Equity Swap

Jan 25 (Reuters) - Henan Taloph Pharmaceutical Stock Co Ltd <600222.SS>::SAYS IT PLANS TO BOOST UNIT'S CAPITAL BY 319.3 MILLION YUAN ($47.20 million) VIA DEBT-TO-EQUITY SWAP.

Henan Taloph Pharmaceutical To Buy Back Company Shares Worth 20-250 Million Yuan

Nov 8 (Reuters) - Henan Taloph Pharmaceutical Stock Co Ltd <600222.SS>::SAYS IT PLANS TO BUY BACK COMPANY SHARES WORTH 20-250 MILLION YUAN ($2.89-36.07 million) WITHIN SIX MONTHS.

Henan Taloph Pharmaceutical Stock to pay cash dividend of 0.01 yuan per share on June 6

May 31 (Reuters) - Henan Taloph Pharmaceutical Stock Co Ltd <600222.SS>:Says it will pay a cash dividend of 0.01 yuan per share (before tax) for 2017 to shareholders of record on June 5.The company's shares will be traded ex-right and ex-dividend on June 6 and the dividend will be paid on June 6 .

Henan Taloph Pharmaceutical Stock ‍receives permission of clinical trial granted by China FDA

May 28 (Reuters) - Henan Taloph Pharmaceutical Stock Co Ltd <600222.SS> ::Says it received permission of clinical trial granted by China FDA with respect to Chinese traditional medicine which is used for treatment of hyperplasia of mammary glands, breast distention, breast nodules and breast lumps.

Henan Taloph Pharmaceutical Stock passes review of high-tech enterprise recognition

Feb 12(Reuters) - Henan Taloph Pharmaceutical Stock Co Ltd <600222.SS>:Says it passes the review of high-tech enterprise recognition and could enjoy a tax preference of 15 percent for three years.

Henan Taloph Pharmaceutical Stock unit receives GMP certificate

Jan 30 (Reuters) - Henan Taloph Pharmaceutical Stock Co Ltd <600222.SS>:Says wholly owned pharmaceutical unit received goods manufacture practice (GMP) certificate from Zhejiang Food and Drug Administration .Certificate issued to traditional chinese medicine manufactured by the unit and the valid period is until Jan. 23, 2023 .

Henan Taloph Pharmaceutical Stock says change of accounting policy

Aug 21(Reuters) - Henan Taloph Pharmaceutical Stock Co Ltd <600222.SS>:Says it changes accounting policy regarding government subsidy.

Henan Taloph Pharmaceutical Stock to sell 33 pct stake in beverage unit at 2.3 mln yuan

Henan Taloph Pharmaceutical Stock Co Ltd <600222.SS>:Says it to sell 33 percent stake in a 51 percent owned beverage unit to an individual, at price of 2.3 million yuan.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up